> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Blackrock Neurotech Breakthrough Status for Brain Interface
- URL: https://www.fdaweb.com/blackrock-neurotech-breakthrough-status-for-brain-interface/
- Published: 2021-11-16T12:00:00.000Z
- Updated: 2026-09-14T17:22:34.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5150581

FDA has granted Blackrock Neurotech a breakthrough device designation for its MoveAgain Brain Computer Interface System. The device is intended to provide immobile patients the ability to control a mouse cursor, keyboard, mobile device/tablet, wheelchair or prosthetic device by thinking. It comprises an array implanted in the brain, which decodes intended movement from neuronal activity, the company says. “Those signals are then transmitted wirelessly to an external device, such as a cursor or wheelchair, providing people with control of their external environment.”